comparemela.com
Home
Live Updates
Hydroxychloroquine Sulphate - Breaking News
Pages:
Latest Breaking News On - Hydroxychloroquine sulphate - Page 1 : comparemela.com
Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis
MELBOURNE, Australia and NEW YORK, Jan. 24, 2024 Incannex Healthcare Inc. , , a pharmaceutical company developing novel medicinal cannabinoid pharmacotherapies and psychedelic medicine.
United states
Joel latham
Laine yonker
Mark bleackley
Incannex healthcare inc
Edison group
World health organisation
Globenewswire inc
Hydroxychloroquine sulphate
Patient reported outcomes
Scientific officer
Magnetic resonance imaging
Health organisation
Trial assessing tolerability
Securities litigation reform act
Executive officer
vimarsana © 2020. All Rights Reserved.